prr - top 10 australian biotech

Hey fellow holders,

On the back of some expected positive news in the coming month ( most importantly trial updates), as well as recent immunotherapy FDA approvals, PRR is well placed to take advantage of expected imminent NASDAQ listing,

Great company and great management with great integrity - US investors will open up there arms to the LITTLE Aussie Dynamo.

The following summary is a good reminder of how much Prima has progressed over the last 12 month. IMO, Prima is well positioned to challenge as a top 5 -6 Aussie Biotech in CY2011.

Good luck to the Prima management; stakeholders and their wonderful life changing technology.

https://www.macquarie.com.au/edge/article/COMPANY/PRR/31b7cd6f771fe210VgnVCM100000c502890aRCRD/

Biomed (PRR.AU), Australia's 9th largest Pharmaceuticals, Biotechnology & Life Sciences company by market capitalisation, has strengthened above its trend. The 200-day moving average price (MAP) was 14.65c. The price to 200-day MAP ratio is 1.6, a bullish indicator.

Looking forward to the coming month.The above is not advice and DYOR before making any decision.